AstraZeneca And Takeda Ink Deal To Develop Parkinson's Drug
August 30, 2017 at 16:10 PM EDT
AstraZeneca PLC and Takeda Pharmaceutical Company Limited, a Japanese pharma company, have entered into an agreement to jointly develop and commercialize preclinical candidate MEDI1341.
